PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. ONON
6. AAPL
7. TRMD
8. AZN
9. BETR
10. DIS

Go back to PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101
(NASDAQ: PDSB) Delayed: 0.84 --0 (-0%)
Previous Close $0.84    52 Week High $ 
Open $0.82    52 Week Low $ 
Day High $0.88    P/E N/A 
Day Low $0.75    EPS $ 
Volume 13,171,256